Selenium speciation in human serum and its implications for epidemiologic research: A cross-sectional study

Journal of Trace Elements in Medicine and Biology

Volumn 31, Issue , 2015, Pages 1-10

  Vinceti, Marco ^a   Grill, Peter ^b   Malagoli, Carlotta ^a   Filippini, Tommaso ^a   Storani, Simone ^a   Malavolti, Marcella ^a   Michalke, Bernhard ^b  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

Author keywords

Assessment; Cross sectional study; Exposure; Selenium; Selenium species; Serum

Indexed keywords

GLUTATHIONE PEROXIDASE; HUMAN SERUM ALBUMIN; SELENIUM; SELENOCYSTEINE;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CROSS-SECTIONAL STUDY; DIETARY INTAKE; EPIDEMIOLOGICAL DATA; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; ITALY; MALE; MASS SPECTROMETRY; MINERAL METABOLISM; MINERAL SUPPLEMENTATION; POPULATION RESEARCH; PRIORITY JOURNAL; SELENIUM BLOOD LEVEL; SEX DIFFERENCE; SMOKING HABIT; BLOOD; CHEMISTRY; LIFESTYLE; MIDDLE AGED;

ADULT; AGED; CROSS-SECTIONAL STUDIES; FEMALE; GLUTATHIONE PEROXIDASE; HUMANS; ITALY; LIFE STYLE; MALE; MIDDLE AGED; SELENIUM; SELENOCYSTEINE;

EID: 84940164173     PISSN: 0946672X     EISSN: 18783252     Source Type: Journal    
DOI: 10.1016/j.jtemb.2015.02.001     Document Type: Article

References (93)

1. Moyad M.A. Heart healthy=prostate healthy: SELECT, the symbolic end of preventing prostate cancer via heart unhealthy and over anti-oxidation mechanisms. Asian J Androl 2012, 14:243-244.
2. Christensen M.J. Selenium and prostate cancer prevention: what next - if anything?. Cancer Prev Res (Phila) 2014, 7:781-785.
3. Kormos W. On call. In the May 2014 issue, you reported on findings from the Selenium and Vitamin E Cancer Prevention Trial (SELECT), which said that taking vitamin E and selenium raises the risk of prostate cancer. My multivitamin contains both of these nutrients. Should I worry?. Harv Men's Health Watch 2014, 19:2.
4. Vinceti M., Maraldi T., Bergomi M., Malagoli C. Risk of chronic low-dose selenium overexposure in humans: insights from epidemiology and biochemistry. Rev Environ Health 2009, 24:231-248.
5. Cavelaars A.E., Kadvan A., Doets E.L., Tepsic J., Novakovic R., Dhonukshe-Rutten R., et al. Nutri-RecQuest: a web-based search engine on current micronutrient recommendations. Eur J Clin Nutr 2010, 64(Suppl. 2):S43-S47.
6. Fairweather-Tait S.J., Bao Y., Broadley M.R., Collings R., Ford D., Hesketh J.E., et al. Selenium in human health and disease. Antioxid Redox Signal 2011, 14:1337-1383.
7. Vinceti M., Dennert G., Crespi C.M., Zwahlen M., Brinkman M., Zeegers M.P., et al. Selenium for preventing cancer. Cochrane Database Syst Rev 2014, 3:CD005195.
8. Vinceti M., Crespi C.M., Malagoli C., Del Giovane C., Krogh V. Friend or foe? The current epidemiologic evidence on selenium and human cancer risk. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev 2013, 31:305-341.
9. Duffield-Lillico A.J., Slate E.H., Reid M.E., Turnbull B.W., Wilkins P.A., Combs G.F., et al. Selenium supplementation and secondary prevention of nonmelanoma skin cancer in a randomized trial. J Natl Cancer Inst 2003, 95:1477-1481.
10. Martinez E.E., Darke A.K., Tangen C.M., Goodman P.J., Fowke J.H., Klein E.A., et al. A functional variant in NKX3.1 associated with prostate cancer risk in the Selenium and Vitamin E Cancer Prevention Trial (SELECT). Cancer Prev Res (Phila) 2014, 7:950-957.
11. Albanes D., Till C., Klein E.A., Goodman P.J., Mondul A.M., Weinstein S.J., et al. Plasma tocopherols and risk of prostate cancer in the Selenium and Vitamin E Cancer Prevention Trial (SELECT). Cancer Prev Res (Phila) 2014, 7:886-895.
12. Anonymous Selenium and vitamin E raise risk of prostate cancer. Harv Men's Health Watch 2014, 18:8.
13. Rees K., Hartley L., Day C., Flowers N., Clarke A., Stranges S. Selenium supplementation for the primary prevention of cardiovascular disease. Cochrane Database Syst Rev 2013, 1:CD009671.
14. Vinceti M., Grioni S., Alber D., Consonni D., Malagoli C., Agnoli C., et al. Toenail selenium and risk of type 2 diabetes: the ORDET cohort study. J Trace Elem Med Biol 2015, 29:145-150.
15. Vinceti M., Mandrioli J., Borella P., Michalke B., Tsatsakis A., Finkelstein Y. Selenium neurotoxicity in humans: bridging laboratory and epidemiologic studies. Toxicol Lett 2014, 230:295-303.
16. Colangelo L.A., He K., Whooley M.A., Daviglus M.L., Morris S., Liu K. Selenium exposure and depressive symptoms: The Coronary Artery Risk Development in Young Adults Trace Element Study. Neurotoxicology 2014, 41:167-174.
17. Ode A., Rylander L., Gustafsson P., Lundh T., Kallen K., Olofsson P., et al. Manganese and selenium concentrations in umbilical cord serum and attention deficit hyperactivity disorder in childhood. Environ Res 2015, 137C:373-381.
18. Ashton K., Hooper L., Harvey L.J., Hurst R., Casgrain A., Fairweather-Tait S.J. Methods of assessment of selenium status in humans: a systematic review. Am J Clin Nutr 2009, 89:2025S-2039S.
19. Letsiou S., Nomikos T., Panagiotakos D.B., Pergantis S.A., Fragopoulou E., Pitsavos C., et al. Gender-specific distribution of selenium to serum selenoproteins: associations with total selenium levels, age, smoking, body mass index, and physical activity. Biofactors 2014, 40:524-535.
20. Solovyev N., Berthele A., Michalke B. Selenium speciation in paired serum and cerebrospinal fluid samples. Anal Bioanal Chem 2013, 405:1875-1884.
21. Weekley C.M., Harris H.H. Which form is that? The importance of selenium speciation and metabolism in the prevention and treatment of disease. Chem Soc Rev 2013, 42:8870-8894.
22. Michalke B., Berthele A. Contribution to selenium speciation in cerebrospinal fluid samples. J Anal Atom Spectrom 2011, 26:165-170.
23. Gammelgaard B., Jackson M.I., Gabel-Jensen C. Surveying selenium speciation from soil to cell - forms and transformations. Anal Bioanal Chem 2011, 399:1743-1763.
24. Hoefig C.S., Renko K., Kohrle J., Birringer M., Schomburg L. Comparison of different selenocompounds with respect to nutritional value vs. toxicity using liver cells in culture. J Nutr Biochem 2011, 22:945-955.
25. Benko I., Nagy G., Tanczos B., Ungvari E., Sztrik A., Eszenyi P., et al. Subacute toxicity of nano-selenium compared to other selenium species in mice. Environ Toxicol Chem 2012, 31:2812-2820.
26. Guerrero B., Llugany M., Palacios O., Valiente M. Dual effects of different selenium species on wheat. Plant Physiol Biochem 2014, 83:300-307.
27. Bitencourt P.E., Belle L.P., Bonfanti G., Cargnelutti L.O., de Bona K.S., Silva P.S., et al. Differential effects of organic and inorganic selenium compounds on adenosine deaminase activity and scavenger capacity in cerebral cortex slices of young rats. Hum Exp Toxicol 2013, 32:942-949.
28. Weekley C.M., Aitken J.B., Witting P.K., Harris H.H. XAS studies of Se speciation in selenite-fed rats. Metallomics 2014, 6:2193-2203.
29. Xu M., Yang L.N., Wang Q.Q. Quantification of selenium-tagged proteins in human plasma using species-unspecific isotope dilution ICP-DRC-qMS coupled on-line with anion exchange chromatography. J Anal Atom Spectrom 2008, 23:1545-1549.
30. Deutsche Forschungsgemeinschaft (DFG) Selenium in serum. The MAK-collection: Part IV. Biomonitoring methods 2013, 249-263. Wiley-VCH Verlag GmbH &Co. KGaA, Bonn, Germany. T. Göen, A. Hartwig (Eds.).
31. Hollenbach B., Morgenthaler N.G., Struck J., Alonso C., Bergmann A., Kohrle J., et al. New assay for the measurement of selenoprotein P as a sepsis biomarker from serum. J Trace Elem Med Biol 2008, 22:24-32.
32. Ballihaut G., Kilpatrick L.E., Kilpatrick E.L., Davis W.C. Multiple forms of selenoprotein P in a candidate human plasma standard reference material. Metallomics 2012, 4:533-538.
33. Whitcomb B.W., Schisterman E.F. Assays with lower detection limits: implications for epidemiological investigations. Paediatr Perinat Epidemiol 2008, 22:597-602.
34. Forceville X. Seleno-enzymes and seleno-compounds: the two faces of selenium. Crit Care 2006, 10:180.
35. Nogueira C.W., Rocha J.B. Toxicology and pharmacology of selenium: emphasis on synthetic organoselenium compounds. Arch Toxicol 2011, 85:1313-1359.
36. Lee K.H., Jeong D. Bimodal actions of selenium essential for antioxidant and toxic pro-oxidant activities: the selenium paradox (Review). Mol Med Rep 2012, 5:299-304.
37. Lippman S.M., Klein E.A., Goodman P.J., Lucia M.S., Thompson I.M., Ford L.G., et al. Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). J Am Med Assoc 2009, 301:39-51.
38. Marshall J.R., Tangen C.M., Sakr W.A., Wood D.P., Berry D.L., Klein E.A., et al. Phase III trial of selenium to prevent prostate cancer in men with high-grade prostatic intraepithelial neoplasia: SWOG S9917. Cancer Prev Res (Phila) 2011, 4:1761-1769.
39. Algotar A.M., Stratton M.S., Ahmann F.R., Ranger-Moore J., Nagle R.B., Thompson P.A., et al. Phase 3 clinical trial investigating the effect of selenium supplementation in men at high-risk for prostate cancer. Prostate 2013, 73:328-335.
40. Karp D.D., Lee S.J., Keller S.M., Wright G.S., Aisner S., Belinsky S.A., et al. Randomized, double-blind, placebo-controlled, phase III chemoprevention trial of selenium supplementation in patients with resected stage I non-small-cell lung cancer: ECOG 5597. J Clin Oncol 2013, 31:4179-4187.
41. Kristal A.R., Darke A.K., Morris J.S., Tangen C.M., Goodman P.J., Thompson I.M., et al. Baseline selenium status and effects of selenium and vitamin E supplementation on prostate cancer risk. J Natl Cancer Inst 2014, 106:djt456.
42. Vinceti M., Crespi C.M., Malagoli C., Bottecchi I., Ferrari A., Sieri S., et al. A case-control study of the risk of cutaneous melanoma associated with three selenium exposure indicators. Tumori 2012, 98:287-295.
43. Vinceti M., Crespi C.M., Bonvicini F., Malagoli C., Ferrante M., Marmiroli S., et al. The need for a reassessment of the safe upper limit of selenium in drinking water. Sci Total Environ 2013, 443:633-642.
44. Bogden J.D., Kemp F.W., Buse M., Thind I.S., Louria D.B., Forgacs J., et al. Composition of tobaccos from countries with high or low incidence of lung cancer: I. Selenium, polonium-210, Alternaria, tar, and nicotine. J Natl Cancer Inst 1981, 66:27-31.
45. Heck J.E., Park A.S., Qiu J., Cockburn M., Ritz B. Risk of leukemia in relation to exposure to ambient air toxics in pregnancy and early childhood. Int J Hyg Environ Health 2014, 217:662-668.
46. Li S., Xiao T., Zheng B. Medical geology of arsenic, selenium and thallium in China. Sci Total Environ 2012, 421-422:31-40.
47. Goen T., Schaller B., Jager T., Brau-Dumler C., Schaller K.H., Drexler H. Biological monitoring of exposure and effects in workers employed in a selenium-processing plant. Int Arch Occup Environ Health 2014, [in press]. 10.1007/s00420-014-0989-7.
48. Gilbertson K., Jarrett R., Bayliss S.J., Berk D.R. Scalp discoloration from selenium sulfide shampoo: a case series and review of the literature. Pediatr Dermatol 2012, 29:84-88.
49. Haldimann M., Venner T.Y., Zimmerli B. Determination of selenium in the serum of healthy Swiss adults and correlation to dietary intake. J Trace Elem Med Biol 1996, 10:31-45.
50. Vinceti M., Wei E.T., Malagoli C., Bergomi M., Vivoli G. Adverse health effects of selenium in humans. Rev Environ Health 2001, 16:233-251.
51. Vinceti M., Solovyev N., Mandrioli J., Crespi C.M., Bonvicini F., Arcolin E., et al. Cerebrospinal fluid of newly diagnosed amyotrophic lateral sclerosis patients exhibits abnormal levels of selenium species including elevated selenite. Neurotoxicology 2013, 38:25-32.
52. Borella P., Bargellini A., Medici C.I. Chemical form of selenium greatly affects metal uptake and responses by cultured human lymphocytes. Biol Trace Elem Res 1996, 51:43-54.
53. Michalke B., Nischwitz V. Review on metal speciation analysis in cerebrospinal fluid-current methods and results: a review. Anal Chim Acta 2010, 682:23-36.
54. Michalke B., Halbach S., Nischwitz V. JEM spotlight: metal speciation related to neurotoxicity in humans. J Environ Monit 2009, 11:939-954.
55. Lipiec E., Siara G., Bierla K., Ouerdane L., Szpunar J. Determination of selenomethionine, selenocysteine, and inorganic selenium in eggs by HPLC-inductively coupled plasma mass spectrometry. Anal Bioanal Chem 2010, 397:731-741.
56. Tsai C.Y., Jiang S.J. Microwave-assisted extraction and ion chromatography dynamic reaction cell inductively coupled plasma mass spectrometry for the speciation analysis of arsenic and selenium in cereals. Anal Sci 2011, 27:271-276.
57. Misra S., Peak D., Chen N., Hamilton C., Niyogi S. Tissue-specific accumulation and speciation of selenium in rainbow trout (Oncorhynchus mykiss) exposed to elevated dietary selenomethionine. Comp Biochem Physiol C Toxicol Pharmacol 2012, 155:560-565.
58. Moreda-Pineiro J., Moreda-Pineiro A., Romaris-Hortas V., Dominguez-Gonzalez R., Alonso-Rodriguez E., Lopez-Mahia P., et al. In vitro bioavailability of total selenium and selenium species from seafood. Food Chem 2013, 139:872-877.
59. Rayman M.P., Infante H.G., Sargent M. Food-chain selenium and human health: spotlight on speciation. Br J Nutr 2008, 100:238-253.
60. Ferri T., Frasconi M. Determination of Se(IV) and Se(VI) in Italian mineral waters. Ann Chim 2006, 96:647-656.
61. Gammelgaard B., Sturup S., Christensen M.V. Human urinary excretion and metabolism of (82)Se-enriched selenite and selenate determined by LC-ICP-MS. Metallomics 2012, 4:149-155.
62. Jager T., Drexler H., Goen T. Human metabolism and renal excretion of selenium compounds after oral ingestion of sodium selenate dependent on trimethylselenium ion (TMSe) status. Arch Toxicol 2014, [in press]. 10.1007/s00204-014-1380-x.
63. Kamble P., Mohsin N., Jha A., Date A., Upadhaya A., Mohammad E., et al. Selenium intoxication with selenite broth resulting in acute renal failure and severe gastritis. Saudi J Kidney Dis Transpl 2009, 20:106-111.
64. Rigby M.C., Lemly A.D., Gerads R. Fish toxicity testing with selenomethionine spiked feed - what's the real question being asked. Environ Sci Process Impacts 2014, 16:511-517.
65. Cemeli E., Marcos R., Anderson D. Genotoxic and antigenotoxic properties of selenium compounds in the in vitro micronucleus assay with human whole blood lymphocytes and TK6 lymphoblastoid cells. Sci World J 2006, 6:1202-1210.
66. Harisa G.I. Oxidative stress and paraoxonase activity in experimental selenosis: effects of betaine administration. Biol Trace Elem Res 2013, 152:258-266.
67. Palsamy P., Bidasee K.R., Shinohara T. Selenite cataracts: activation of endoplasmic reticulum stress and loss of Nrf2/Keap1-dependent stress protection. Biochim Biophys Acta 2014, 1842:1794-1805.
68. Chen Y., Mo H.Z., Hu L.B., Li Y.Q., Chen J., Yang L.F. The endogenous nitric oxide mediates selenium-induced phytotoxicity by promoting ros generation in Brassica rapa. PLOS ONE 2014, 9:e110901.
69. Manolopoulos K.N., Klotz L.O., Korsten P., Bornstein S.R., Barthel A. Linking Alzheimer's disease to insulin resistance: the FoxO response to oxidative stress. Mol Psychiatry 2010, 15:1046-1052.
70. Holmgren A. Antioxidant function of thioredoxin and glutaredoxin systems. Antioxid Redox Signal 2000, 2:811-820.
71. Labunskyy V.M., Hatfield D.L., Gladyshev V.N. Selenoproteins: molecular pathways and physiological roles. Physiol Rev 2014, 94:739-777.
72. Misu H., Takamura T., Takayama H., Hayashi H., Matsuzawa-Nagata N., Kurita S., et al. A liver-derived secretory protein, selenoprotein P, causes insulin resistance. Cell Metab 2010, 12:483-495.
73. Pinto A., Speckmann B., Heisler M., Sies H., Steinbrenner H. Delaying of insulin signal transduction in skeletal muscle cells by selenium compounds. J Inorg Biochem 2011, 105:812-820.
74. Mao J., Teng W. The relationship between selenoprotein P and glucose metabolism in experimental studies. Nutrients 2013, 5:1937-1948.
75. Reid M.E., Duffield-Lillico A.J., Garland L., Turnbull B.W., Clark L.C., Marshall J.R. Selenium supplementation and lung cancer incidence: an update of the nutritional prevention of cancer trial. Cancer Epidemiol Biomarkers Prev 2002, 11:1285-1291.
76. Ellingsen D.G., Thomassen Y., Rustad P., Molander P., Aaseth J. The time-trend and the relation between smoking and circulating selenium concentrations in Norway. J Trace Elem Med Biol 2009, 23:107-115.
77. Sun H., Chen W., Wang D., Jin Y., Chen X., Xu Y. The effects of prenatal exposure to low-level cadmium, lead and selenium on birth outcomes. Chemosphere 2014, 108:33-39.
78. Robberecht H., Deelstra H. Factors influencing blood selenium concentration values: a literature review. J Trace Elem Electrolytes Health Dis 1994, 8:129-143.
79. Jossa F., Trevisan M., Krogh V., Farinaro E., Giumetti D., Fusco G., et al. Serum selenium and coronary heart disease risk factors in southern Italian men. Atherosclerosis 1991, 87:129-134.
80. Blazewicz A., Klatka M., Astel A., Korona-Glowniak I., Dolliver W., Szwerc W., et al. Serum and urinary selenium levels in obese children: a cross-sectional study. J Trace Elem Med Biol 2015, 29:116-122.
81. 82Se-selenite. Toxicol Appl Pharmacol 2006, 217:185-195.
82. Afridi H.I., Talpur F.N., Kazi T.G., Brabazon D. Assessment of toxic elements in the samples of different cigarettes and their effect on the essential elemental status in the biological samples of Irish hypertensive consumers. J Hum Hypertens 2014, [in press]. 10.1038/jhh.2014.87.
83. Kokarnig S., Tsirigotaki A., Wiesenhofer T., Lackner V., Francesconi K.A., Pergantis S.A., et al. Concurrent quantitative HPLC-mass spectrometry profiling of small selenium species in human serum and urine after ingestion of selenium supplements. J Trace Elem Med Biol 2015, 29:83-90.
84. Morris J.S., Crane S.B. Selenium toxicity from a misformulated dietary supplement, adverse health effects, and the temporal response in the nail biologic monitor. Nutrients 2013, 5:1024-1057.
85. Cuderman P., Stibilj V. How safe are antioxidant food supplements containing selenium?. Acta Chim Slov 2010, 57:668-676.
86. Sunde R.A., Gutzke G.E., Hoekstra W.G. Effect of dietary methionine on the biopotency of selenite and selenomethionine in the rat. J Nutr 1981, 111:76-88.
87. Salbe A.D., Levander O.A. Effect of various dietary factors on the deposition of selenium in the hair and nails of rats. J Nutr 1990, 120:200-206.
88. Behne D., Gessner H., Kyriakopoulos A. Information on the selenium status of several body compartments of rats from the selenium concentrations in blood fractions, hair and nails. J Trace Elem Med Biol 1996, 10:174-179.
89. Hoppe B., Brauer A.U., Kuhbacher M., Savaskan N.E., Behne D., Kyriakopoulos A. Biochemical analysis of selenoprotein expression in brain cell lines and in distinct brain regions. Cell Tissue Res 2008, 332:403-414.
90. Behne D., Alber D., Kyriakopoulos A. Effects of long-term selenium yeast supplementation on selenium status studied in the rat. J Trace Elem Med Biol 2009, 23:258-264.
91. Rueli R.H., Parubrub A.C., Dewing A.S., Hashimoto A.C., Bellinger M.T., Weeber E.J., et al. Increased selenoprotein p in choroid plexus and cerebrospinal fluid in Alzheimer's disease brain. J Alzheimer's Dis 2015, 44:379-383.
92. Fairweather-Tait S.J., Collings R., Hurst R. Selenium bioavailability: current knowledge and future research requirements. Am J Clin Nutr 2010, 91:1484S-1491S.
93. Panter K.E., Hartley W.J., James L.F., Mayland H.F., Stegelmeier B.L., Kechele P.O. Comparative toxicity of selenium from seleno-dl-methionine, sodium selenate, and Astragalus bisulcatus in pigs. Fundam Appl Toxicol 1996, 32:217-223.